• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ULTRAVERSE RX; PTA BALLOON DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ULTRAVERSE RX; PTA BALLOON DILATATION CATHETER Back to Search Results
Model Number U4150415RX
Device Problems Break (1069); Difficult to Remove (1528); Material Rupture (1546); Device-Device Incompatibility (2919); Material Twisted/Bent (2981); Material Split, Cut or Torn (4008)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/22/2022
Event Type  malfunction  
Event Description
It was reported that during an angioplasty procedure of chronic total occlusion in the superficial femoral artery via a contralateral approach, the pta balloon allegedly ruptured at nominal pressure and also the guidewire was bent at the same time.It was further reported that there was resistance felt upon the balloon was retracing and the shaft was found to be torn.Reportedly, the balloon and the guidewire were removed as one unit.The procedure was completed using another device.There was no reported patient injury.
 
Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.The investigation of the reported event is currently underway.(expiration date: 03/2025).
 
Event Description
It was reported that during an angioplasty procedure of chronic total occlusion in the superficial femoral artery via a contralateral approach, the pta balloon allegedly ruptured at 6 atm.It was further reported that there was difficulty in retracting the balloon through the introducer sheath and the device and introducer sheath removed as one unit.Reportedly, there was resistance felt upon when the balloon was retracting and the shaft was found to be torn.Reportedly, the balloon and the guidewire were removed as one unit.The procedure was completed using another device.There was no reported patient injury.
 
Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one ultraverse rx pta dilatation catheter was received for evaluation.During visual evaluation, the entire length of the catheter was examined for damage revealing a longitudinal tear to the clear portion of the catheter.The guidewire lumen and core-wire were exposed.The inner guidewire lumen had twisting, stretching, and bunching.No rupture was noted to the balloon.No functional testing was performed due to the condition of the sample.Therefore, the investigation is confirmed for the reported shaft tear as a longitudinal tear was noted to the clear portion of the catheter.However, the investigation is unconfirmed for the reported balloon rupture as there was no rupture seen on the balloon.Additionally, the investigation is inconclusive for both the reported sheath and guidewire removal difficulty as functional testing could not be performed due to the condition of the sample.A definitive root cause for the reported balloon rupture, sheath removal difficulty, guidewire removal difficulty and shaft tear could not be determined based upon the provided information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one ultraverse rx pta dilatation catheter was received for evaluation.During visual evaluation, the entire length of the catheter was examined for damage revealing a longitudinal tear to the clear portion of the catheter.The guidewire lumen and core-wire were exposed.The inner guidewire lumen had twisting, stretching, and bunching.No rupture was noted to the balloon.No functional testing was performed due to the condition of the sample.Therefore, the investigation is confirmed for the reported shaft tear as a longitudinal tear was noted to the clear portion of the catheter.However, the investigation is inconclusive for the reported balloon rupture as functional testing for the same could not be performed due to the condition of the catheter.Additionally, the investigation is inconclusive for both the reported sheath and guidewire removal difficulty as functional testing could not be performed due to the condition of the sample.A definitive root cause for the reported balloon rupture, sheath removal difficulty, guidewire removal difficulty and shaft tear could not be determined based upon the provided information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: d4 (expiration date: 03/2025), g3.H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that during an angioplasty procedure of chronic total occlusion in the superficial femoral artery via a contralateral approach, the pta balloon allegedly ruptured at 6 atm.It was further reported that there was difficulty in retracting the balloon through the introducer sheath and the device and introducer sheath removed as one unit.Reportedly, there was resistance felt upon when the balloon was retracting and the shaft was found to be torn.Reportedly, the balloon and the guidewire were removed as one unit.The procedure was completed using another device.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAVERSE RX
Type of Device
PTA BALLOON DILATATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
CLEARSTREAM TECHNOLOGIES LTD.
moyne upper
enniscorthy, co. wexford N A
EI   N A
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key15400397
MDR Text Key302725615
Report Number2020394-2022-00734
Device Sequence Number1
Product Code LIT
UDI-Device Identifier00801741057618
UDI-Public(01)00801741057618
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K131199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/12/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberU4150415RX
Device Catalogue NumberU4150415RX
Device Lot NumberCMGR0301
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/11/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/19/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-